Pharmaceuticals

Mutation Detection Kits In Genome Editing Market Growth Expected To Reach $21.76 Billion By 2030 At 13.5% CAGR

May 1, 2026May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Mutation Detection Kits In Genome Editing Market Expected To Reach Based On Its 2026 Value?

The market size for mutation detection kits in genome editing has expanded significantly in recent years. The market is projected to expand from $1.14 billion in 2025 to $1.29 billion in 2026, driven by a compound annual growth rate (CAGR) of 13.2%. Factors contributing to its historical growth include the scarcity of mutation detection kits, a reliance on conventional and manual detection methods, expanding genome editing research, a rising need for accurate validation tools, and the integration of basic nucleic acid reagents.

The market for mutation detection kits in genome editing is projected to witness significant expansion over the next few years. This sector is anticipated to reach a valuation of $2.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.0%. This forecasted growth can be attributed to the advancement of sophisticated CRISPR-based mutation validation kits, increasing investment in next-generation sequencing technologies, the widespread availability of cloud-based bioinformatics solutions, expanding applications in clinical diagnostics and personalized medicine, and the integration of AI-driven tools for data interpretation. Prominent trends expected in this forecast period include the rising adoption of PCR-based and next-generation sequencing mutation detection kits, the increased deployment of CRISPR mutation validation tools in genome editing research, the growth of software solutions for genomic data analysis and visualization, the broadening of mutation detection applications in drug development and clinical diagnostics, and the incorporation of cloud-based bioinformatics platforms for real-time data processing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27356&type=smp

Which Strong Drivers Are Impacting The Mutation Detection Kits In Genome Editing Market Growth?

The escalating incidence of genetic conditions is projected to drive the expansion of mutation detection kits in the genome editing market. Genetic disorders are health problems or states caused by irregularities in an individual’s DNA, which can be passed down from parents or arise from novel genetic mutations. The growth in genetic disorders is attributed to heightened public awareness and advanced diagnostic technologies, enabling earlier and more accurate identification of these conditions, thereby leading to increased reported prevalence rates. Genome editing mutation detection kits help address genetic disorders by precisely identifying disease-causing gene mutations, which facilitates targeted research and the development of accurate therapeutic interventions. For instance, in May 2024, according to the National Health Service, a UK-based government department, approximately 17,000 people in England live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed each year. Thus, the increasing prevalence of genetic disorders is fueling the demand for mutation detection kits in the genome editing market.

What Are The Key Segment Divisions In The Mutation Detection Kits In Genome Editing Market Segment Structure?

The mutation detection kits in genome editing market covered in this report is segmented –

1) By Product Type: Reagents, Kits, Software Solutions

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases Or Meganuclease-TAL Effector Nucleases (TALENs/MegaTALs), Zinc Finger Nucleases (ZFN), Other Technologies

3) By Application: Research, Clinical Diagnostics, Drug Development, Other Applications

4) By End Use: Academic Institutions, Hospitals And Diagnostic Centers, Biotechnology Companies

Subsegments:

1) By Reagents: Deoxyribonucleic Acid Polymerases (DNA) Polymerases, Nucleases, Buffers And Enzymes, Fluorescent Dyes And Probes, Primers And Oligonucleotides

2) By Kits: Polymerase Chain Reaction (PCR)-Based Mutation Detection Kits, Next-Generation Sequencing-Based Mutation Analysis Kits, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Mutation Validation Kits, Gel Electrophoresis-Based Detection Kits

3) By Software Solutions: Mutation Analysis And Visualization Tools, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Off-Target Prediction Software, Genomic Alignment and Annotation Software, Data Interpretation Platforms For Next-Generation Sequencing, Cloud-Based Bioinformatics Platforms

Which Trends Are Shaping The Mutation Detection Kits In Genome Editing Market?

Leading firms in the mutation detection kits sector within the genome editing market are concentrating their efforts on creating sophisticated offerings like ultrasensitive multiplexed assays to improve the precision, rapidity, and responsiveness of genetic mutation identification. These ultrasensitive multiplexed assays represent cutting-edge diagnostic tools capable of concurrently identifying and quantifying numerous genetic mutations even at minute concentrations, thereby enabling researchers and medical professionals to conduct quicker, more precise, and thorough mutation analyses for improved disease assessment and therapy oversight. As an illustration, in April 2024, Bio-Rad Laboratories Inc., a US-based research firm, introduced the ddPLEX ESR1 Mutation Detection Kit, which is an ultrasensitive multiplexed digital PCR assay specifically developed for detecting breast cancer mutations. This particular kit facilitates the concurrent identification and exact measurement of seven ESR1 mutations, offering an analytical sensitivity as low as 0.01% variant allele fraction, and is compatible with both plasma and tissue sample examinations. These kinds of advancements underscore the sector’s dedication to enhancing diagnostic precision and facilitating more efficient disease surveillance and tailored therapeutic approaches.

Which Organizations Are Engaged In The Mutation Detection Kits In Genome Editing Market?

Major companies operating in the mutation detection kits in genome editing market are F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena AG, Twist Bioscience Corporation, New England Biolabs Inc., Applied Biological Materials Inc., Synthego Corporation, BioVision Inc., Creative Biogene Corporation

Get The Full Mutation Detection Kits In Genome Editing Market Report:

https://www.thebusinessresearchcompany.com/report/mutation-detection-kits-in-genome-editing-global-market-report

Which Region Dominates The Mutation Detection Kits In Genome Editing Market By Market Share?

North America was the largest region in the mutation detection kits in genome editing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mutation detection kits in genome editing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Mutation Detection Kits In Genome Editing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/mutation-detection-kits-in-genome-editing-global-market-report

Browse Through More Reports Similar to the Global Mutation Detection Kits In Genome Editing Market 2026, By The Business Research Company

Pet Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-insurance-global-market-report

Pet Healthcare Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-healthcare-global-market-report

Accidental Death Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/accidental-death-insurance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795